Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.

http://www.wikidata.org/entity/Q33898749

about

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.A Novel Method to Identify Differential Pathways in Hippocampus Alzheimer's Disease Diagnostic value of blood thiamine metabolites in Alzheimer's disease examined by 11C-PiB PET scanning Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease.Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease.Systemic immune system alterations in early stages of Alzheimer's disease.Biomarkers of basic activities of daily living in Alzheimer's disease.Significance of serum immune markers in identification of global functional impairment in the oldest old: cross-sectional results from the BELFRAIL study.Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.Strong Association between Plasma Dipeptidyl Peptidase-4 Activity and Impaired Cognitive Function in Elderly Population with Normal Glucose Tolerance.Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer's disease.Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis.There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease.Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer's disease.Overcoming biofluid protein complexity during targeted mass spectrometry detection and quantification of protein biomarkers by MRM cubed (MRM3).Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease.Stress-Induced Alterations of Immune Profile in Animals Suffering by Tau Protein-Driven Neurodegeneration.Peripheral cytokines, C-X-C motif ligand10 and interleukin-13, are associated with Malaysian Alzheimer's disease.Levels of IL-8 and TNF-α decrease in Parkinson's disease.

P2860

Q33626656-3152D5E4-D95F-4DF9-A19D-5124E6B099F2 Q33702839-A903B1D0-D078-4D45-BF35-5215AF5A838E Q33827082-59E9A3BD-FBF7-4DFE-B99A-B50FD4D2E600 Q34277859-24CBCD3C-721E-46A7-B0C6-35F92429B4BE Q35106592-AEE1FFD1-6E65-481E-BB25-603FEEA3D6A9 Q36145503-3E15CBF6-0F1C-484F-9600-35D629DB44BD Q36529533-79B4D762-A1DB-48E1-9561-6E848229A1CD Q36595660-85BEBCAB-8D12-4F47-9842-464D5FCFAD8A Q36622309-F80DB0CB-C072-4F44-9BCA-59CD0B110EE7 Q36810980-6D4D1E3C-D01B-4819-AD1A-21A83B833A53 Q36818214-DF6AF31F-F621-4F10-A239-EB4F81DD0A80 Q37470982-38EAA6A4-640F-4FBA-8419-DF2782B079B6 Q37654102-2628A5B8-27F7-4D0C-B405-3C6995C7799D Q38060638-96275C8F-AE5B-48C4-BE4B-044C3696F6EA Q38189680-6EB239A0-DCA5-43C0-84CB-FE644AFB3A8C Q38629516-6F246FAE-926C-4FF0-9FD1-E2A3A4D43B97 Q39372809-9B8B2A90-9C7F-40FE-B0A7-D3E0F3DB3F1C Q40507310-9DD63ABD-92F2-4F0A-A00B-66930B6EDA24 Q41381108-10B9DFA4-1BB3-44A4-8968-C0806F69FF2B Q43590134-506DE132-5D99-4D25-B4C4-63D31FAF75E0 Q47878656-F2BA86A7-444E-4838-87A7-A7FC7464DA99 Q48257794-5C6BBF3A-F3C8-4156-8601-CEA619179CD4 Q48281041-757A0EE4-07AA-4B7D-A7EF-D4C250243589 Q48717553-8AFF4E79-C215-49E2-9839-63105B5A036E Q50908798-FB0392F9-FF6E-4092-847C-1FF9683279FA

P2860

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.

http://www.wikidata.org/entity/Q33898749

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Identification of peripheral i ...... ntrol and Alzheimer's disease.

@ast

Identification of peripheral i ...... ntrol and Alzheimer's disease.

@en

type

label

Identification of peripheral i ...... ntrol and Alzheimer's disease.

@ast

Identification of peripheral i ...... ntrol and Alzheimer's disease.

@en

prefLabel

Identification of peripheral i ...... ntrol and Alzheimer's disease.

@ast

Identification of peripheral i ...... ntrol and Alzheimer's disease.

@en

P1433

Q33898749-2A79DB01-D5A0-4CE9-9570-1AE7614EBA56

P1476

Q33898749-97592720-EF37-4096-9120-DFAEB1E38689

P2093

Q33898749-38E0633E-5B15-4884-B4F4-3E61542F5AE3

Q33898749-3FAB9BA4-974A-496F-8BB7-B903FD7A9B5C

Q33898749-70BD7882-C5B5-49B9-BD16-5599EDA4F080

Q33898749-7353EC7D-DF98-45F4-9FA0-76D95818B3A4

Q33898749-9E548C13-5393-4964-B42D-F5EB09BABC73

Q33898749-B7331E4D-CD76-4ED4-A33F-CE5522EC4E55

Q33898749-F24A8D8E-3124-42A7-BBE9-BEA1D15AE275

P2860

Q33898749-15076EB2-5F10-44F8-9013-BD3C456D96F8

Q33898749-1B186837-1B6E-4431-A30B-5E0B6661AB44

Q33898749-1C8EBA4D-FB52-42D0-BF32-2CDCB32458EF

Q33898749-2F24B69B-96FA-41FC-9E62-BB15BBCE11FC

Q33898749-35FF6154-B570-4AD4-9BB1-6D1D34D75771

Q33898749-378A0621-C87B-4C34-8D55-6765C000BF59

Q33898749-3A1D79F3-7771-4B21-8987-BA6819D1A5A8

Q33898749-403C13DD-5470-4509-9CBA-D308281AA0C2

Q33898749-4047C352-6FBC-47C1-86A6-F9A6409F8B08

Q33898749-5314CA6E-9754-411F-A97B-26CF5DA46C9F

P2888

Q33898749-87AD2F55-F7A2-4CE7-BD2A-B6C28F9F00C1

P304

Q33898749-2A97B8E1-D91D-4004-A7F6-9C52BFE0B36B

P31

Q33898749-63301CC6-AE38-4505-ACC0-E7F96404F237

P356

Q33898749-FFB6846A-A556-414D-A2E6-0CABA37BAF01

P478

Q33898749-1EACABE6-234A-45AF-B85A-C6F1C3700FE1

P50

Q33898749-4E9B0AF4-67D5-45C5-B34D-0D9DE4D8E80B

P577

Q33898749-09C11B1E-54BE-470D-9BCA-064B6B836515

P5875

Q33898749-F96550AD-B530-4006-B660-786F44371A62

P6179

Q33898749-8980A07F-DE00-4152-9B9B-3F9F88FBBD84

P698

Q33898749-390A5188-D2A3-4F4C-B69B-08C78125CC22

P921

Q33898749-14E4C4B9-2D66-4D65-B0B5-7C4077D791C3

P932

Q33898749-34099B21-EF05-4630-B5EE-452CC4BF511B

P356

1471-2377-11-51

P1433

P1476

Identification of peripheral i ...... ontrol and Alzheimer's disease

@en

P2093

Juhee Song

http://www.w3.org/2001/XMLSchema#string

Moon Ho Park

http://www.w3.org/2001/XMLSchema#string

Sam-Moon Kim

http://www.w3.org/2001/XMLSchema#string

Sangmee Ahn Jo

http://www.w3.org/2001/XMLSchema#string

Seungwoo Kim

http://www.w3.org/2001/XMLSchema#string

Young-Youl Kim

http://www.w3.org/2001/XMLSchema#string

Youngho Koh

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Inflammation and Alzheimer's disease

Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha

Control of synaptic strength by glial TNFalpha

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.

No difference in stroke knowledge between Korean adherents to traditional and western medicine - the AGE study: an epidemiological study.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Current concepts in mild cognitive impairment.

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

Interleukin-10 in the brain.

P2888

1471-2377-11-51

P304

51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2377-11-51

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51123967

http://www.w3.org/2001/XMLSchema#string

P6179

1036185453

http://www.w3.org/2001/XMLSchema#string

P698

21569380

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3120663

http://www.w3.org/2001/XMLSchema#string